Traditional Chinese Medicine (TCM) Institute of Kidney Disease was founded in 2004 in Shanghai University of TCM. Combined the theory of Chinese medicine with cutting-edge biomedical approaches, basic and clinical research projects were carried out in the institute, which cover major issues in the field of kidney diseases such as chronic kidney failure, IgA nephropathy, diabetic nephropathy, chronic nephritis, inherited kidney disease (ADPKD) and vascular calcification associated with chronic kidney disease (CKD).
1. Funded projects: 70 projects were founded from 2014 to 2021, including 14 projects from the National Natural Science Foundation of China (8 general projects, 6 youth projects), and 18 provincial and ministerial projects. The total funding was nearly 30 million RMB.
2. Academic awards: 10 awards were received including the first prize of Shanghai Science and Technology Progress Award.
3. Published papers: 336 papers were published including 44 SCI articles. The total impact factor is 109.6. Ten articles have an impact factor over 5.
4. Patent: 4 national invention patents were authorized.
5. Monographs: 8 books were published.
6. Expert consensus: Professor Chaoyang Ye is a major writer of Chinese Expert Consensus of Hemodialysis Vascular Access (edition 2014, 2019), and one of the responsible editors to formulate the 2020 version of the National Blood Purification Standard Operating Procedure.
Our ongoing activities
Several lines of project are ongoing in our institute focusing on preventing renal fibrosis and delaying chronic renal failure.
1. A series of traditional Chinese medicine to prevent and treat chronic kidney fibrosis (He Liqun).
2. The mechanism and clinical practice of Yiqi Huoxue Chinese medicine in preventing and treating chronic renal failure with massive proteinuria (Wang Chen).
3. Shizhi prescription Chinese medicine for the treatment of chronic hyperuric acid nephropathy in stage 2-4 clinically. (Gao Jiandong).
4. Integrating traditional Chinese and Western medicine to maintain the survival rate and quality of life in the end-stage of chronic kidney disease (CKD5) (Ye Chaoyang).
5. Epigenetic regulation in the progression of chronic kidney disease (Wu Ming and Ye Chaoyang)
Currently our institute is led by Professor Ye Chaoyang. There are 28 team members, with an average age of 40 years old, including 5 full-time researchers. Fifteen of them have senior titles, 11 staffs have intermediate titles, and 2 staffs have junior titles. Fourteen staffs have PhD or MD degree, and 14 of them have master degree. We have 4 doctoral student supervisors and 7 master student supervisors.
Address: No.528 Zhangheng Road, Pudong District, Shanghai 201203, PR China